Health committee  Yes, that's correct.

Health committee  Yes, that's right.

Health committee  So I'm expecting as much time as it took you to ask me the question. Thank you. I'll explain the situation. The rule said that I couldn't meet with the minister. I was told that my position was equivalent to that of a deputy minister reporting to a minister and that I had to wait to be called by the minister to meet him.

Health committee  I had asked my secretary.

Health committee  I will conclude. I asked to meet him. I didn't get a reply. I officially asked to meet the minister in connection with his letter of November 28, 2022. You'll see my request in the letter of November 30, 2022 that was addressed to him. This led to a meeting on November30, 2022, not with the minister, but with Mr.

Health committee  I made the request internally, but it wasn't followed up.

Health committee  Do you want to know whether I received threats directly or if I had heard about any?

Health committee  I think we've all heard about threats of this kind in the media.

Health committee  Yes I was worried about that.

Health committee  I would ask you to read the submissions that were made in connection with the last consultation period. They are available online. They show the various concerns that were expressed, including from groups of patients. There was also a peer-reviewed scientific paper on the subject.

Health committee  Yes.

Health committee  I'm speaking here today as an individual. The proposed guidelines could have involved a risk from the legal standpoint. They could even have made it possible to indirectly do things that could not be done directly. That's why I felt it was appropriate to take the time to read them closely.

Health committee  I don't know. It's something that would have to be looked at in depth., Hence the importance of holding consultations on the subject.

Health committee  Are you talking about the PMPRB's proposed guidelines?

Health committee  As I said in my presentation, is the PMPRB's role strictly to ensure that the price of patented medicines is not excessive, or is it a body that ensures access to medicines at a price that is not excessive? There's a big difference there. To give you a short answer, please read the briefs presented during the last or second-last consultation period.